Follow
Adam Idoine
Adam Idoine
Carnegie Institution for Science
Verified email at carnegie.edu
Title
Cited by
Cited by
Year
Systems analysis of the response of photosynthesis, metabolism, and growth to an increase in irradiance in the photosynthetic model organism Chlamydomonas reinhardtii
T Mettler, T Mühlhaus, D Hemme, MA Schöttler, J Rupprecht, A Idoine, ...
The Plant Cell 26 (6), 2310-2350, 2014
1372014
The mitochondrial alternative oxidase from Chlamydomonas reinhardtii enables survival in high light
Y Kaye, W Huang, S Clowez, S Saroussi, A Idoine, E Sanz-Luque, ...
Journal of Biological Chemistry 294 (4), 1380-1395, 2019
432019
Zanubrutinib versus ibrutinib in relapsed/refractory chronic lymphocytic leukemia and small lymphocytic lymphoma: interim analysis of a randomized phase III trial
P Hillmen, B Eichhorst, JR Brown, N Lamanna, SM O'Brien, CS Tam, ...
Journal of Clinical Oncology 41 (5), 1035, 2023
352023
Zanubrutinib in patients with previously treated B-cell malignancies intolerant of previous Bruton tyrosine kinase inhibitors in the USA: a phase 2, open-label, single-arm study
M Shadman, IW Flinn, MY Levy, RF Porter, JM Burke, SF Zafar, J Misleh, ...
The Lancet Haematology 10 (1), e35-e45, 2023
352023
Construction of a shuttle vector using an endogenous plasmid from the cyanobacterium Synechocystis sp. PCC6803
H Jin, Y Wang, D Bhaya
Frontiers in microbiology 9, 345780, 2018
352018
The diurnal logic of the expression of the chloroplast genome in Chlamydomonas reinhardtii
AD Idoine, A Boulouis, J Rupprecht, R Bock
PLoS One 9 (10), e108760, 2014
272014
The HIV-1 Pr55gag polyprotein binds to plastidial membranes and leads to severe impairment of chloroplast biogenesis and seedling lethality in transplastomic …
N Scotti, L Sannino, A Idoine, P Hamman, A De Stradis, P Giorio, ...
Transgenic Research 24, 319-331, 2015
182015
Preliminary results of the phase 2 study of zanubrutinib in patients with previously treated B‐cell malignancies intolerant to ibrutinib and/or acalabrutinib
M Shadman, JP Sharman, MY Levy, R Porter, SF Zafar, JM Burke, ...
Hematological Oncology 39, 2021
92021
Recombination in feline lentiviral genomes during experimental cross-species infection
M Poss, A Idoine, HA Ross, JA Terwee, S VandeWoude, A Rodrigo
Virology 359 (1), 146-151, 2007
92007
Zanubrutinib in acalabrutinib-intolerant patients (pts) with B-cell malignancies
M Shadman, IW Flinn, EC Kingsley, B Freeman, MY Levy, H Holmes, ...
Blood 140 (Supplement 1), 3655-3657, 2022
82022
Acquired Mutations in Patients (Pts) with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) That Progressed in the ALPINE Study
JR Brown, J Li, BF Eichhorst, N Lamanna, SM O'Brien, CS Tam, L Qiu, ...
Blood 142, 1890, 2023
12023
Zanubrutinib in acalabrutinib-intolerant patients (pts) with B-cell malignancies
M Shadman, IW Flinn, EC Kingsley, BB Freeman, M Levy, CM Farber, ...
Blood 142, 3279, 2023
12023
PB1890: zanubrutinib in acalabrutinib-intolerant patients (PTS) with B-cell malignancies
M Shadman, IW Flinn, EC Kingsley, B Freeman, MY Levy, J Cultrera, ...
HemaSphere 6, 1769-1770, 2022
12022
Genomic landscape of patients in a phase II study of zanubrutinib in ibrutinib-and/or acalabrutinib-intolerant patients with B-cell malignancies
L Xu, M Shadman, IW Flinn, MY Levy, R Porter, JM Burke, SF Zafar, ...
Haematologica, 2020
12020
OP112 Evaluation Of A Self-Administered Smart Phone-Based Application As A Wellness Measure In A Clinical Trial Of Zanubrutinib
R Crescenzo, A Idoine, K Yang
International Journal of Technology Assessment in Health Care 39 (S1), S31-S31, 2023
2023
Genomic Landscape of Ibrutinib-and/or Acalabrutinib-intolerant Patients with B-cell Malignancies Treated with Zanubrutinib in a Phase 2 Study
L Xu, M Shadman, IW Flinn, M Levy, R Porter, JM Burke, SF Zafar, ...
Blood 142, 6510, 2023
2023
P633: UPDATED SAFETY AND EFFICACY RESULTS OF ZANUBRUTINIB IN PATIENTS WITH B-CELL MALIGNANCIES WHO ARE INTOLERANT OF IBRUTINIB AND/OR ACALABRUTINIB
M Shadman, MY Levy, R Porter, JM Burke, JL Cultrera, J Misleh, ...
HemaSphere 7 (S3), e70152b3, 2023
2023
Zanubrutinib in patients with B-cell malignancies intolerant to ibrutinib and/or acalabrutinib
M Shadman, J Sharman, M Levy, R Porter, SF Zafar, JM Burke, ...
Leukemia and Lymphoma, S117-S118, 2021
2021
Validation of Abiotic Bacterial Surrogates for Surface Sanitation in Food Processing Facilities
N Herbold, A Idoine, P Mattei, J Atchley, S Johnson, L Clotilde, Q Chou, ...
IAFP 2019 Annual Meeting, 2019
2019
Evaluation of Abiotic Bacterial Surrogates for Validation and Verification of One-pass Produce Wash Systems
L Clotilde, X Nou, Y Luo, E Wilhelmsen, A Idoine, B Zhou, S Bolten, G Gu, ...
IAFP 2019 Annual Meeting, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–20